Filing Flows

Filing Flows › Consumer Staples › Stepan (SCL)

Stepan (SCL) earnings and revenue breakdown

Latest: Q3 2026 · 10-Q filed Nov 4, 2026 · Stepan (SCL) Q3 2026 earnings results →

Q3 2026 Revenue up 17% year over year to $692M · 3¢ of every $1 of revenue kept as net profit · operating margin 3.8%

Stepan made $692M in Q3 2026 (+17% Y/Y): Surfactants $487M, Polymers $179M, Specialty Products $26.9M. Operating margin 3.8%, net earnings $17.8M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 4, 2026.

Revenue$692M
Year over year+17%
Operating margin3.8%
Net earnings$17.8M
Operating cash flow$29.3M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $692.2M in Q3 2026, up 17% year over year and up 1% from the previous quarter. Surfactants was the largest line at 70% of revenue. Surfactants added $64.3M year over year (up 15%), 63% of the total change.

Gross margin was 12.7%, up 0.6 points from Q3 2025. Operating profit was $26.0M, a 3.8% margin (up 0.1 points year over year). Of the extra revenue versus Q3 2025, 4% reached operating profit, above the 4% margin then. Operating expenses grew 25% against revenue growth of 17%. The fastest-growing cost line was Other operating costs (+41%). Net earnings were $17.8M, up 64% year over year. The effective tax rate was 10.2%.

Operating cash flow was $29.3M (down 58% year over year), 165% of net earnings. Non-cash charges added back $31.3M of depreciation and amortization and $2.2M of share-based compensation. Working capital and other items used $21.9M. Capital expenditures of $21.2M left free cash flow of $8.2M.

Quarterly history

Stepan revenue by quarterStepan revenue by quarter$593MQ1 2025$595MQ2 2025$590MQ3 2025$554MQ4 2025$605MQ1 2026$684MQ2 2026$692MQ3 2026
Stepan net earnings by quarterStepan net earnings by quarter$19.7MQ1 2025$11.3MQ2 2025$10.8MQ3 2025$5.0MQ4 2025−$41.4MQ1 2026$22.9MQ2 2026$17.8MQ3 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q3 202610-QNov 4, 2026$692M+17%3.8%$17.8M$29.3M
Q2 202610-QAug 5, 2026$684M+15%5.4%$22.9M$8.4M
Q1 202610-QMay 6, 2026$605M+2%-8.2%−$41.4M$16.9M
Q4 202510-KFeb 26, 2026$554M+5%1.9%$5.0M$60.0M
Q3 202510-QNov 5, 2025$590M+8%3.7%$10.8M$69.8M
Q2 202510-QAug 6, 2025$595M+7%3.0%$11.3M$11.2M
Q1 202510-QMay 7, 2025$593M+8%4.8%$19.7M$6.9M

Charts

Stepan: revenue growth, year over year and quarter over quarterStepan: revenue growth, year over year and quarter over quarterY/YQ/Q+8%Q1 2025+7%+0%Q2 2025+8%-1%Q3 2025+5%-6%Q4 2025+2%+9%Q1 2026+15%+13%Q2 2026+17%+1%Q3 2026
Latest (Q3 2026): Y/Y +17%, Q/Q +1%.
Stepan: where the cash came from (+) and went (−), TTM to Q3 2026Stepan: where the cash came from (+) and went (−), TTM to Q3 2026Operating cash flow$115MCapital spending−$110MDividends−$35.9MOther investing$34.6MOther financing−$24.9MCash drawn (+) / kept (−)$20.4MExchange rates$899KShares issued$294K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Stepan: profit against cash, quarter by quarterStepan: profit against cash, quarter by quarterNet incomeOperating cash flow$3.4M$68.3MQ4 2024$19.7M$6.9MQ1 2025$11.3M$11.2MQ2 2025$10.8M$69.8MQ3 2025$5.0M$60.0MQ4 2025−$41.4M$16.9MQ1 2026$22.9M$8.4MQ2 2026$17.8M$29.3MQ3 2026
Latest (Q3 2026): Net income $17.8M, Operating cash flow $29.3M.
Stepan: diluted shares by fiscal yearStepan: diluted shares by fiscal year23MFY202023MFY202123MFY202223MFY202323MFY202423MFY2025
-1.6% since FY2020: buybacks shrank the count.
Stepan: long-term debt falling due (FY2025)Stepan: long-term debt falling due (FY2025)$286M2026$136M2027$45.0M2028$40.0M2029$40.0M2030$80.7MLater
Cash $133M, short-term investments —, long-term debt $627M at 2025-12-31.
Stepan in its industry: growth against margin (6 companies, SIC 2840)Stepan in its industry: growth against margin (6 companies, SIC 2840)revenue growth, year over year →↑ operating marginmedian +13%median 17%PGECLCHDXAGEORIBSCL (+17%, 4%)
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

Stepan against its Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +17% against the peers' median +13%. Operating margin: 3.8% against the peers' median 17.3%.

CompanyQuarterRevenueY/YOp. margin
SCL StepanQ3 2026$692M+17%3.8%
PG Procter & GambleQ1 FY27$23.3B+4%25.5%
ECL EcolabQ3 2026$4.7B+13%17.3%
CHD Church & DwightQ3 2026$1.6B+1%18.2%
XAGE Longevity Health HoldingsQ2 2026$396K-21%-182.9%
ORIB Orion BlissQ1 FY27$12K+300%-32.0%

Source: Stepan 10-Q on SEC EDGAR · CIK 94049 · Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics

Guidance and outlook

Stepan: what its forward-looking statements are about (10-Q filed 2026-11-04)Stepan: what its forward-looking statements are about (10-Q filed 2026-11-04)People6Other4Costs2Capital spending2
14 statements; tone -0.14 (−1 all cautious, +1 all confident); 1 hedged.
Stepan: outlook statements against the filing beforeStepan: outlook statements against the filing beforeCautious2

13F: who owns SCL and who is buying

Largest holders of SCL (13F)Largest holders of SCL (13F)BlackRock$193MVanguard Group$122MHighTower Advisors, LLC$88.6MVanguard Portfolio Management LLC$77.0MDimensional Fund Advisors LP$62.7MDeprince Race & Zollo$56.9MVanguard Capital Management LLC$52.9MAmerican Century Companies$52.9MState Street$49.5MGeode Capital Management, LLC$31.5M
Funds' net buying of SCL by quarter (13F)Funds' net buying of SCL by quarter (13F)$5.1M2024-09$6.3M2024-12$1.4M2025-03$14.3M2025-06$9.6M2025-09−$3.1M2025-12$8.5M2026-03$16.8M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on SCL

History

Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results

Compare SCL with

中文版:Stepan(SCL)财报

Español · Français